期刊文献+

超选择性动脉溶栓与静脉溶栓对老年急性脑梗死的疗效对比 被引量:19

超选择性动脉溶栓与静脉溶栓对老年急性脑梗死的疗效对比
暂未订购
导出
摘要 目的分析超选择性动脉溶栓与静脉溶栓对老年急性脑梗死的疗效和安全性并进行对比。方法将2010~2012年就诊的63例老年急性脑梗死患者随机分成实验组与对照组,实验组31例,采用尿激酶超选择性动脉溶栓治疗;对照组32例,行静脉溶栓治疗。两组分别于溶栓前和溶栓后的30min、2h、12h、24h、3d、7d、14d按美国国立卫生院卒中评分(NIHSS)进行神经功能缺损程度评分及按欧洲脑卒中评分标准(ESS)评价治疗效果并统计治愈情况。结果治疗后实验组平均NIHSS评分为(8.7±2.3),对照组为(10.6±2.9),实验组低于对照组(P<0.05);实验组平均ESS评分为(80.79±14.26),对照组平均评分为(72.31±14.13),实验组平均ESS评分显著优于对照组(P<0.05)。结论采用尿激酶超选择性动脉溶栓与静脉溶栓都有较好的疗效和安全性,但超选择性动脉溶栓疗法优于静脉溶栓,在临床上具有推广意义。 Objective To discuss about the therapeutical effect of supperselected intraaterial thrombolysis and venous thrombolysis treating senile acute cerebral infarction and then make a comparison. Methods Pick up the patients who developed acute cerebral infarction in our from 2010 to 2012, diving them into experimental and control groups randomLy. Control group (32 cases) took the venous thrombolysis, the experimental group (31 cases) took supperselected intraaterial thrombolysis. All the patients are scored by NIHSS and ESS standard before and after their treatment. Results NIHSS score of experimental group (8.7±2.3) was significantly lower than control group (10.6±2.9) ESS score of experimental group (80.79±14.26) was better than control group (72.31±14.13). Conclusion Supperselected intraaterial thrombolysis and venous thrombolysis are both good ways in treating senile acute cerebral infarction, but the supperselected intraaterial thrombolysis is better, providing the meaning for clinical promotion.
出处 《当代医学》 2013年第9期3-4,共2页 Contemporary Medicine
关键词 超选择性动脉溶栓 静脉溶栓 急性脑梗死 Supperselected intraaterial thrombolysis Venous thrombolysis Acute cerebral infarction
  • 相关文献

参考文献6

二级参考文献31

共引文献42

同被引文献142

  • 1胡大一,周自强,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状流行病学研究[J].中国心脏起搏与心电生理杂志,2004,18(Z1):3-6.
  • 2金丽,李晓芸,郑大勇.急性前循环脑梗死老年患者准介入溶栓治疗疗效及安全性[J].中国老年学杂志,2014,34(8):2241-2242. 被引量:14
  • 3裘丽红,韩新生.选择性动脉介入溶栓治疗急性脑梗死临床疗效观察[J].临床荟萃,2005,20(19):1107-1108. 被引量:4
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33089
  • 5薛慎伍,张兆岩,薛源.老年脑卒中防治进展与新技术[M].北京:人民军医出版社,2012.269-271.
  • 6Haley E C Jr, Thompson J L,Grotta J C,et al. Phase IIB/III trial of tenecteplase in acute ischemic stroke- results of a pre- maturely terminated randomized clinical trial[J]. Stroke, 2010, 41(4):707-711.
  • 7Sugg R M, Noser E A, Shaltoni H M, et al. Intra arterial rete- plase compared to urokinase for thrombotytic recanalization in acute ischemic stroke[J]. AJNR Am J Neuroradiol, 2006,27 (4) :769-773.
  • 8Lees K R,Bluhmki E,von Kummer R,et al. Time to treat- ment with intravenous alteplase and outcome in stroke;an up- dated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J]. Lancet, 2010,375 (9727) : 1695-1703.
  • 9Ciccone A, Valvassori L, Ponzio M, et al. Intra-arterial or in- travenous thrombolysis for acute ischemie stroke? The SYN- THESIS pilot trial[J]. J Neurointerv Surg, 2010,2 (1) : 74-79.
  • 10Broderick J P,Palesch Y Y,Demchuk A M, et al. Endovascular therapy alter intravenous t-PA versus t-PA alone for stroke[J]. N Engl J Meal,2013,368(10) :893-903.

引证文献19

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部